About Sino Biopharmaceutical
Sino Biopharmaceutical is a company based in Hong Kong (China) founded in 2000.. The company has 24,380 employees as of December 31, 2024. Sino Biopharmaceutical has completed 1 acquisition, including Softhale. Sino Biopharmaceutical offers products and services including Oncology Drugs and Liver Disease Treatments.
- Headquarter Hong Kong, China
- Employees 24380 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sino Biopharmaceutical Limited
-
Annual Revenue
$4.03 B (USD)8.11as on Dec 31, 2024
-
Net Profit
$249.79 M (USD)-24.69as on Dec 31, 2024
-
EBITDA
$1.05 B (USD)8.64as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
24380
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sino Biopharmaceutical
Sino Biopharmaceutical is a publicly listed company on the HKEX with ticker symbol 1177 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sino Biopharmaceutical
Sino Biopharmaceutical offers a comprehensive portfolio of products and services, including Oncology Drugs and Liver Disease Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drugs for tumor areas are developed and distributed as part of the company's focus on key therapeutic domains
Treatments for liver disease are provided through the company's research-driven pharmaceutical operations
Unlock access to complete
Finance and Accounting
4 people
Leadership Team
2 people
Sales and Marketing
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of Sino Biopharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Sino Biopharmaceutical
Sino Biopharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Softhale. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Inhalation devices for targeted drug delivery to lungs are developed.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sino Biopharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sino Biopharmaceutical Comparisons
Competitors of Sino Biopharmaceutical
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sino Biopharmaceutical
Frequently Asked Questions about Sino Biopharmaceutical
When was Sino Biopharmaceutical founded?
Sino Biopharmaceutical was founded in 2000.
Where is Sino Biopharmaceutical located?
Sino Biopharmaceutical is headquartered in Hong Kong, China.
Who is the current CEO of Sino Biopharmaceutical?
Tse Ping is the current CEO of Sino Biopharmaceutical.
How many employees does Sino Biopharmaceutical have?
As of Dec 31, 2024, the latest employee count at Sino Biopharmaceutical is 24,380.
What is the annual revenue of Sino Biopharmaceutical?
Annual revenue of Sino Biopharmaceutical is $4.03B as on Dec 31, 2024.
What does Sino Biopharmaceutical do?
Founded in 2000 and headquartered in Hong Kong, China, Sino Biopharmaceutical operates in the pharmaceutical sector with a focus on generics for cardio-cerebral diseases and hepatitis. Medicines are also developed for tumors, analgesia, orthopedic conditions, anti-infection treatments, parenteral nutrition, respiratory issues, anorectal diseases, diabetes, and other areas. In 2021, annual revenues of 3.84 billion were recorded, alongside a net profit of 1.54 billion.
What products or services does Sino Biopharmaceutical offer?
Sino Biopharmaceutical offers Oncology Drugs and Liver Disease Treatments.
Is Sino Biopharmaceutical publicly traded?
Yes, Sino Biopharmaceutical is publicly traded on HKEX under the ticker symbol 1177.
How many acquisitions has Sino Biopharmaceutical made?
Sino Biopharmaceutical has made 1 acquisition, including Softhale.
What is Sino Biopharmaceutical's ticker symbol?
The ticker symbol of Sino Biopharmaceutical is 1177 on HKEX.